1. Home
  2. ZLAB vs OSIS Comparison

ZLAB vs OSIS Comparison

Compare ZLAB & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • OSIS
  • Stock Information
  • Founded
  • ZLAB 2013
  • OSIS 1987
  • Country
  • ZLAB China
  • OSIS United States
  • Employees
  • ZLAB N/A
  • OSIS N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • OSIS Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • OSIS Technology
  • Exchange
  • ZLAB Nasdaq
  • OSIS Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • OSIS 3.4B
  • IPO Year
  • ZLAB 2017
  • OSIS 1997
  • Fundamental
  • Price
  • ZLAB $29.25
  • OSIS $223.52
  • Analyst Decision
  • ZLAB Buy
  • OSIS Strong Buy
  • Analyst Count
  • ZLAB 4
  • OSIS 6
  • Target Price
  • ZLAB $47.37
  • OSIS $228.33
  • AVG Volume (30 Days)
  • ZLAB 1.4M
  • OSIS 222.2K
  • Earning Date
  • ZLAB 05-08-2025
  • OSIS 05-01-2025
  • Dividend Yield
  • ZLAB N/A
  • OSIS N/A
  • EPS Growth
  • ZLAB N/A
  • OSIS 13.25
  • EPS
  • ZLAB N/A
  • OSIS 8.23
  • Revenue
  • ZLAB $398,988,000.00
  • OSIS $1,689,088,000.00
  • Revenue This Year
  • ZLAB $44.43
  • OSIS $12.56
  • Revenue Next Year
  • ZLAB $48.68
  • OSIS $5.14
  • P/E Ratio
  • ZLAB N/A
  • OSIS $27.20
  • Revenue Growth
  • ZLAB 49.59
  • OSIS 14.93
  • 52 Week Low
  • ZLAB $15.65
  • OSIS $129.18
  • 52 Week High
  • ZLAB $39.77
  • OSIS $227.34
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 38.00
  • OSIS 68.77
  • Support Level
  • ZLAB $30.96
  • OSIS $215.34
  • Resistance Level
  • ZLAB $32.02
  • OSIS $227.34
  • Average True Range (ATR)
  • ZLAB 1.14
  • OSIS 7.05
  • MACD
  • ZLAB -0.27
  • OSIS 2.69
  • Stochastic Oscillator
  • ZLAB 4.87
  • OSIS 93.44

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

Share on Social Networks: